Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Devon running sensation claims triple gold win in her age range

Devon running sensation claims triple gold win in her age range

Neutral Devon Live
Owner: Reach PLC
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

Celltrion Begins Sales of Bone Disease Therapy Stoboclo–Osenvelt in Europe

Celltrion Begins Sales of Bone Disease Therapy Stoboclo–Osenvelt in Europe

Celltrion launches Stovoclo and Osenvelt bone disease treatments in major European markets

Celltrion launches Stovoclo and Osenvelt bone disease treatments in major European markets

Readers sound off on holiday absurdity, Portugal’s drug model and NYCHA problems

Readers sound off on holiday absurdity, Portugal’s drug model and NYCHA problems

Portugal recovers bodies of two Indonesian fishermen lost at sea

Portugal recovers bodies of two Indonesian fishermen lost at sea

NBCC delivers world-class global health landmark: redeveloped WHO–SEARO headquarters inaugurated

NBCC delivers world-class global health landmark: redeveloped WHO–SEARO headquarters inaugurated

Portuguese Connection? How the Brown Shooting and the Death of MIT Professor Nuno Loureiro May Be Related

Portuguese Connection? How the Brown Shooting and the Death of MIT Professor Nuno Loureiro May Be Related

Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

Celltrion Begins Sales of Bone Disease Therapy Stoboclo–Osenvelt in Europe

Celltrion Begins Sales of Bone Disease Therapy Stoboclo–Osenvelt in Europe

Celltrion launches Stovoclo and Osenvelt bone disease treatments in major European markets

Celltrion launches Stovoclo and Osenvelt bone disease treatments in major European markets

Readers sound off on holiday absurdity, Portugal’s drug model and NYCHA problems

Readers sound off on holiday absurdity, Portugal’s drug model and NYCHA problems

Portugal recovers bodies of two Indonesian fishermen lost at sea

Portugal recovers bodies of two Indonesian fishermen lost at sea

NBCC delivers world-class global health landmark: redeveloped WHO–SEARO headquarters inaugurated

NBCC delivers world-class global health landmark: redeveloped WHO–SEARO headquarters inaugurated

Portuguese Connection? How the Brown Shooting and the Death of MIT Professor Nuno Loureiro May Be Related

Portuguese Connection? How the Brown Shooting and the Death of MIT Professor Nuno Loureiro May Be Related

Devon running sensation claims triple gold win in her age range

Devon running sensation claims triple gold win in her age range

Show More

Video Stories

YouTube video thumbnail: Which Grapes Went Into Which Bottle? The Food Detectives Bring Perfect Clarity to Douro Wine
Play
Which Grapes Went Into Which Bottle? The Food Detectives Bring Perfect Clarity to Douro Wine
YouTube video thumbnail: Is Lisbon as Dreamy as it Looks on Instagram?
Play
Is Lisbon as Dreamy as it Looks on Instagram?
YouTube video thumbnail: Equestrian art in Portugal
Play
Equestrian art in Portugal
YouTube video thumbnail: Has Portugal Won its War on Drugs?
Play
Has Portugal Won its War on Drugs?

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions